Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
NCT07551882Phase 2Recruiting
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2024
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxytocin nasal spray in borderline personality disorder (BPD) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Self Compassion Scale Short Form at 1 month. Started Jan 2024; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT07551882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07551882.